Persistent inflammation in HIV infection: Established concepts, new perspectives

Immunology Letters

Volumn 161, Issue 2, 2014, Pages 184-188

  Nasi, Milena ^a   Pinti, Marcello ^a   Mussini, Cristina ^a,b   Cossarizza, Andrea ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

AIDS, CD4; HIV; Immune activation; Inflammation

Indexed keywords

CYTOKINE; NUCLEIC ACID; TOLL LIKE RECEPTOR; AUTACOID;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSTIMULATION; INNATE IMMUNITY; INTESTINE EPITHELIUM; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; LYMPHOID TISSUE; MACROPHAGE; METABOLISM; MICROBIOLOGY; PATHOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LYMPHOID TISSUE; MACROPHAGES;

EID: 84906794202     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.01.008     Document Type: Article

References (61)

1. Anton P.A., Elliott J., Poles M.A., McGowan I.M., Matud J., Hultin L.E., et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 2000, 14:1761-1765.
2. Poles M.A., Fuerst M., McGowan I., Elliott J., Rezaei A., Mark D., et al. HIV-related diarrhea is multifactorial and fat malabsorption is commonly present, independent of HAART. Am J Gastroenterol 2001, 96:1831-1837.
3. Li Z., Xiong Y., Peng Y., Pan J., Chen Y., Wu X., et al. Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis. FEBS Lett 2005, 579:3100-3106.
4. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434:1093-1097.
5. Guadalupe M., Reay E., Sankaran S., Prindiville T., Flamm J., McNeil A., et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003, 77:11708-11717.
6. Mehandru S., Poles M.A., Tenner-Racz K., Jean-Pierre P., Manuelli V., Lopez P., et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med 2006, 3:e484.
7. Mehandru S., Poles M.A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004, 200:761-770.
8. Mavigner M., Cazabat M., Dubois M., L'Faqihi F.E., Requena M., Pasquier C., et al. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 2012, 122:62-69.
9. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007, 8:1390-1397.
10. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8:950-957.
11. Ancuta P., Kamat A., Kunstman K.J., Kim E.Y., Autissier P., Wurcel A., et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 2008, 3:e2516.
12. Kim C.J., McKinnon L.R., Kovacs C., Kandel G., Huibner S., Chege D., et al. Mucosal Th17 cell function is altered during HIV infection and is an independent predictor of systemic immune activation. J Immunol 2013, 191:2164-2173.
13. Shen R., Richter H.E., Clements R.H., Novak L., Huff K., Bimczok D., et al. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J Virol 2009, 83:3258-3267.
14. Waki K., Freed E.O. Macrophages and cell-cell spread of HIV-1. Viruses 2010, 2:1603-1620.
15. Allers K., Fehr M., Conrad K., Epple H.J., Schurmann D., Geelhaar-Karsch A., et al. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients. J Infect Dis 2013.
16. Herbein G., Varin A. The macrophage in HIV-1 infection: from activation to deactivation?. Retrovirology 2010, 7:33.
17. Brenchley J.M., Douek D.C. The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008, 3:356-361.
18. Nazli A., Chan O., Dobson-Belaire W.N., Ouellet M., Tremblay M.J., Gray-Owen S.D., et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010, 6:e1000852.
19. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
20. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371.
21. Wallet M.A., Rodriguez C.A., Yin L., Saporta S., Chinratanapisit S., Hou W., et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 2010, 24:1281-1290.
22. Estes J.D., Harris L.D., Klatt N.R., Tabb B., Pittaluga S., Paiardini M., et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010, 6:e1001052.
23. Marchetti G., Cozzi-Lepri A., Merlini E., Bellistri G.M., Castagna A., Galli M., et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 2011, 25:1385-1394.
24. Nowroozalizadeh S., Mansson F., da Silva Z., Repits J., Dabo B., Pereira C., et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis 2010, 201:1150-1154.
25. Vassallo M., Mercie P., Cottalorda J., Ticchioni M., Dellamonica P. The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review. Virol J 2012, 9:174.
26. Klatt N.R., Funderburg N.T., Brenchley J.M. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013, 21:6-13.
27. Brenchley J.M. Mucosal immunity in human and simian immunodeficiency lentivirus infections. Mucosal Immunol 2013, 6:657-665.
28. Baroncelli S., Galluzzo C.M., Pirillo M.F., Mancini M.G., Weimer L.E., Andreotti M., et al. Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA. J Clin Virol 2009, 46:367-370.
29. McMichael A.J., Borrow P., Tomaras G.D., Goonetilleke N., Haynes B.F. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 2010, 10:11-23.
30. Cossarizza A., Ortolani C., Mussini C., Borghi V., Guaraldi G., Mongiardo N., et al. Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis 1995, 172:105-112.
31. Norris P.J., Pappalardo B.L., Custer B., Spotts G., Hecht F.M., Busch M.P. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses 2006, 22:757-762.
32. Picker L.J. Immunopathogenesis of acute AIDS virus infection. Curr Opin Immunol 2006, 18:399-405.
33. Cossarizza A., Mussini C., Mongiardo N., Borghi V., Sabbatini A., De Rienzo B., et al. Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS 1997, 11:19-26.
34. Franceschi C., Franceschini M.G., Boschini A., Trenti T., Nuzzo C., Castellani G., et al. Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+ long term non progressors. Cell Death Differ 1997, 4:815-823.
35. Streeck H., Nixon D.F. T cell immunity in acute HIV-1 infection. J Infect Dis 2010, 202(Suppl 2):S302-S308.
36. Catalfamo M., Di Mascio M., Hu Z., Srinivasula S., Thaker V., Adelsberger J., et al. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. PNAS 2008, 105:19851-19856.
37. Pinti M., Troiano L., Nasi M., Bellodi C., Ferraresi R., Mussi C., et al. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century. Circulation 2004, 110:3108-3114.
38. Cummins N.W., Badley A.D. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis 2010, 1:e99.
39. Jiao Y., Fu J., Xing S., Fu B., Zhang Z., Shi M., et al. The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressors. Immunology 2009, 128:e366-e375.
40. Funderburg N., Luciano A.A., Jiang W., Rodriguez B., Sieg S.F., Lederman M.M. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 2008, 3:e1915.
41. Khaitan A., Unutmaz D. Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep 2011, 8:4-11.
42. Wherry E.J., Blattman J.N., Murali-Krishna K., van der Most R., Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003, 77:4911-4927.
43. Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006, 12:1198-1202.
44. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
45. Zhang J.Y., Zhang Z., Wang X., Fu J.L., Yao J., Jiao Y., et al. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007, 109:4671-4678.
46. Jones R.B., Ndhlovu L.C., Barbour J.D., Sheth P.M., Jha A.R., Long B.R., et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008, 205:2763-2779.
47. Said E.A., Dupuy F.P., Trautmann L., Zhang Y., Shi Y., El-Far M., et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 2010, 16:452-459.
48. Estes J.D., Haase A.T., Schacker T.W. The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche. Semin Immunol 2008, 20:181-186.
49. Schacker T. The role of secondary lymphatic tissue in immune deficiency of HIV infection. AIDS 2008, 22(Suppl 3):S13-S18.
50. Schacker T.W., Reilly C., Beilman G.J., Taylor J., Skarda D., Krason D., et al. Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count. AIDS 2005, 19:2169-2171.
51. Diaz A., Alos L., Leon A., Mozos A., Caballero M., Martinez A., et al. Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients. AIDS 2010, 24:2029-2039.
52. Mogensen T.H., Melchjorsen J., Larsen C.S., Paludan S.R. Innate immune recognition and activation during HIV infection. Retrovirology 2010, 7:54.
53. Abbink T.E., Berkhout B. HIV-1 reverse transcription initiation: a potential target for novel antivirals. Virus Res 2008, 134:4-18.
54. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
55. Solis M., Nakhaei P., Jalalirad M., Lacoste J., Douville R., Arguello M., et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 2011, 85:1224-1236.
56. Berg R.K., Melchjorsen J., Rintahaka J., Diget E., Soby S., Horan K.A., et al. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS One 2012, 7:e29291.
57. Gao D., Wu J., Wu Y.T., Du F., Aroh C., Yan N., et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013, 341:903-906.
58. Jakobsen M.R., Bak R.O., Andersen A., Berg R.K., Jensen S.B., Jin T., et al. From the Cover: IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. PNAS 2013, 110:E4571-E4580.
59. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
60. Cossarizza A., Pinti M., Nasi M., Gibellini L., Manzini S., Roat E., et al. Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. Mitochondrion 2011, 11:750-755.
61. Pinti M., Mussini C., Cossarizza A. Mitochondrial DNA: a proinflammatory 'enemy from within' during HIV infection?. Cell Death Dis 2012, 3:307.